Tertiary lymphoid structures in pulmonary metastases of microsatellite stable colorectal cancer.


Journal

Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 01 03 2023
accepted: 05 06 2023
revised: 08 05 2023
medline: 10 7 2023
pubmed: 20 6 2023
entrez: 19 6 2023
Statut: ppublish

Résumé

Tertiary lymphoid structures (TLSs) are ectopic lymphoid aggregates located at sites of chronic inflammation and recognized as prognosticators in several cancers. We aimed to analyse the prognostic effect of TLSs in colorectal cancer (CRC) pulmonary metastases and primary tumours, with a comparison to the CD3

Identifiants

pubmed: 37337034
doi: 10.1007/s00428-023-03577-8
pii: 10.1007/s00428-023-03577-8
pmc: PMC10326136
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-32

Informations de copyright

© 2023. The Author(s).

Références

BMC Cancer. 2022 Aug 22;22(1):911
pubmed: 35996090
Gut. 2010 Oct;59(10):1383-8
pubmed: 20732912
Nat Rev Immunol. 2014 Jul;14(7):447-62
pubmed: 24948366
Br J Surg. 2010 May;97(5):772-81
pubmed: 20306528
J Natl Cancer Inst. 2016 May 12;108(8):
pubmed: 27172903
Clin Cancer Res. 2009 Oct 15;15(20):6412-20
pubmed: 19825961
Ann Thorac Surg. 2006 Jun;81(6):2008-13
pubmed: 16731121
Clin Exp Metastasis. 2016 Oct;33(7):727-39
pubmed: 27449756
Cancer Immunol Immunother. 2018 Mar;67(3):435-444
pubmed: 29204700
Anticancer Res. 2020 Nov;40(11):6367-6373
pubmed: 33109574
Scand J Gastroenterol. 2014 Oct;49(10):1153-63
pubmed: 25144865
J Clin Oncol. 2008 Sep 20;26(27):4410-7
pubmed: 18802153
Cancers (Basel). 2022 Dec 29;15(1):
pubmed: 36612204
Mod Pathol. 1990 May;3(3):332-5
pubmed: 2362940
Lancet. 2018 May 26;391(10135):2128-2139
pubmed: 29754777
Front Immunol. 2019 Aug 22;10:1884
pubmed: 31507584
Genes Dev. 2018 Oct 1;32(19-20):1267-1284
pubmed: 30275043
Cancer Cell Int. 2021 Oct 15;21(1):536
pubmed: 34654433
Am J Clin Pathol. 2013 Apr;139(4):434-41
pubmed: 23525613
Trends Immunol. 2014 Nov;35(11):571-80
pubmed: 25443495
Front Immunol. 2017 Dec 19;8:1830
pubmed: 29312327
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Cancers (Basel). 2021 Mar 26;13(7):
pubmed: 33810354
Int J Cancer. 2014 May 1;134(9):2126-35
pubmed: 24154855
Front Oncol. 2022 Apr 28;12:888181
pubmed: 35574322
BJS Open. 2020 Aug;4(4):685-692
pubmed: 32543788

Auteurs

Topias Karjula (T)

Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Aapistie 5a, 90220, Oulu, Finland. topias.karjula@oulu.fi.

Anne Niskakangas (A)

Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Aapistie 5a, 90220, Oulu, Finland.

Olli Mustonen (O)

Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Aapistie 5a, 90220, Oulu, Finland.

Iiris Puro (I)

Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Aapistie 5a, 90220, Oulu, Finland.

Hanna Elomaa (H)

Department of Biological and Environmental Science, University of Jyväskylä, 40014, Jyväskylä, Finland.
Department of Education and Research, Central Finland Health Care District, 40620, Jyväskylä, Finland.

Maarit Ahtiainen (M)

Department of Pathology, Central Finland Health Care District, 40620, Jyväskylä, Finland.

Teijo Kuopio (T)

Department of Biological and Environmental Science, University of Jyväskylä, 40014, Jyväskylä, Finland.
Department of Pathology, Central Finland Health Care District, 40620, Jyväskylä, Finland.

Jukka-Pekka Mecklin (JP)

Department of Education and Research, Central Finland Health Care District, 40620, Jyväskylä, Finland.
Faculty of Sport and Health Sciences, University of Jyväskylä, 40014, Jyväskylä, Finland.

Toni T Seppälä (TT)

Faculty of Medicine and Health Technology, Tampere University and TAYS Cancer Center, Tampere University Hospital, 33520, Tampere, Finland.
Department of Gastrointestinal Surgery, Helsinki University Central Hospital, University of Helsinki, 00290, Helsinki, Finland.
Applied Tumor Genomics, Research Program Unit, University of Helsinki, 00290, Helsinki, Finland.

Erkki-Ville Wirta (EV)

Faculty of Medicine and Health Technology, Tampere University and TAYS Cancer Center, Tampere University Hospital, 33520, Tampere, Finland.
Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, 33520, Tampere, Finland.

Eero Sihvo (E)

Central Hospital of Central Finland, 40014, Jyväskylä, Finland.

Fredrik Yannopoulos (F)

Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Aapistie 5a, 90220, Oulu, Finland.
Department of Cardiothoracic Surgery, Oulu University Hospital, Oulu, Finland.

Olli Helminen (O)

Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Aapistie 5a, 90220, Oulu, Finland.

Juha P Väyrynen (JP)

Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Aapistie 5a, 90220, Oulu, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH